Head and Neck Cancer


Targeted radiotherapy for head and neck cancer could reduce the risk of dry mouth (February 22, 2017)

A troublesome side effect of radiation therapy treatment of cancers involving the head and neck is dry mouth.  This occurs as a consequence of radiation damage to the salivary glands.  According to a... Continue Reading

Nearly half of U.S. men actively infected with HPV, study finds HPV-linked cancers on the rise in men, but nearly 9 in 10 vaccine-eligible men are unvaccinated! (February 20, 2017)

By Rachel Tompa / Fred Hutch News Service The most common sexually transmitted infection in the U.S. has a bit of a twist. It’s what’s known as a “subclinical infection” — those infected suffer... Continue Reading

2016-Year in Review: Advances in Management of Head and Neck Cancer (February 16, 2017)

Globally, head and neck cancer (HNC) comprises the seventh most common type of cancer with an estimated 400,000-600,000 diagnoses every year. 2016 saw significant advances in understanding the role of... Continue Reading

Twice-daily radiation therapy reduces mortality from head and neck cancer (February 14, 2017)

Treating head and neck cancer patients with a twice-daily radiation therapy schedule combined with chemotherapy could save more lives, according to new research presented at the European Cancer Congress... Continue Reading

Personalized Treatment with Erbitux in Head and Neck Cancer Promising (February 8, 2017)

Researchers from UCLA have reported that a short course of the drug Erbitux® (cetuximab) in combination with standard chemotherapy and radiation improves survival in individuals diagnosed with advanced... Continue Reading

Opdivo Approved for Advanced Head and Neck Cancer (November 28, 2016)

The United States Food and Drug Administration (FDA) has approved the immunotherapeutic agent, Opdivo® (nivolumab) for the treatment of advanced head and neck cancer. Specifically,  the indication is... Continue Reading

Head and Neck Cancer- Your Questions Answered (October 17, 2016)

CancerConnect and The Ohio State University Comprehensive Cancer Center- James Cancer Hospital and Solove Research Institute Present: Ask the Expert with Dr. Kang CancerConnect in collaboration with The... Continue Reading

Particular HPV Strain Linked to Improved Prognosis for Throat Cancer (October 17, 2016)

When it comes to cancer-causing viruses like human papillomavirus, or HPV, researchers are continuing to find that infection with one strain may be better than another. In an analysis of survival data... Continue Reading

Ask the Head and Neck Cancer Expert- Q&A Now Available! (October 14, 2016)

CancerConnect and The Ohio State University Comprehensive Cancer Center- James Cancer Hospital and Solove Research Institute Will Present: Ask the Expert with Dr. Kang CancerConnect in collaboration with... Continue Reading

PET/CT Combined More Effective Than MRI in Monitoring Head and Neck Cancer Patients’ Response to Treatment (October 5, 2016)

According to a recent study, combining PET/CT to monitor response to treatment in head and neck cancer patients appears more effective than MRI. Using PET/CT may better inform doctors whether treatment... Continue Reading

Announcing the CancerConnect Head and Neck Cancer Support Community (September 14, 2016)

Your story matters. Head and neck cancer is a challenging diagnosis, connecting with others who have had to deal with the side effects of treatment and the challenges of treatment decision making is an... Continue Reading

Head and Neck Cancer Immunotherapy Study with AXAL Advances to Second Stage (August 29, 2016)

Advaxis, Inc. (ADXS), a clinical-stage biotechnology company developing cancer immunotherapies, today announced that its Phase 2 “window of opportunity” clinical study of its lead immunotherapy candidate,... Continue Reading

Keytruda® Approved for Advanced Head and Neck Cancer (August 24, 2016)

The United States Food and Drug Administration (FDA) has approved Keytruda® (pembrolizumab) for the treatment of advanced head and neck cancer that has stopped responding to platinum-based chemotherapy... Continue Reading

Lip and Oral Cavity Cancer (June 28, 2016)

Lip and oral cavity cancer is a disease in which cancer cells form in the lips or mouth.  The oral cavity includes the lips, hard palate (the bony front portion of the roof of the mouth), soft palate... Continue Reading

Early Stage I- III Salivary Gland Cancer (June 23, 2016)

Overview Early stage salivary gland cancers are small, localized, and highly curable when treated with surgery and/or radiation therapy. Early stage disease includes stage I, II, and most stage III cancers.... Continue Reading

Treatment of Advanced Salivary Gland Cancer (June 22, 2016)

Overview Advanced salivary gland cancers are those that are too large to be effectively cured with surgery and or have already spread or metastasized to other locations in the body. Treatment with surgery... Continue Reading

General Information About Salivary Gland Cancer (June 22, 2016)

Cancer of the salivary glands is one of many head and neck cancers. There are three main pairs of salivary glands in and around the mouth and throat that produce and release saliva into your mouth.  The... Continue Reading

What Causes Head and Neck Cancer? (June 16, 2016)

There are approximately 53,000 head and neck cancers diagnosed annually in the United States. They are twice as common among men as they are among occur more often among people over age 50. Alcohol and... Continue Reading

Next Page »

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS